Beyond medication: What else does the patient with schizophrenia need to reintegrate into the community?

Journal of Psychosocial Nursing and Mental Health Services

Volumn 35, Issue 9, 1997, Pages 18-21

  Castle, Lynne Noel ^a,b  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

^b Box 354 ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLOZAPINE; NEUROLEPTIC AGENT;

ADULT; ARTICLE; CONTROL; DAILY LIFE ACTIVITY; FEMALE; HUMAN; MALE; METHODOLOGY; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; PSYCHOLOGICAL ASPECT; PSYCHOLOGY; PSYCHOTHERAPY; SCHIZOPHRENIA; SOCIAL ADAPTATION;

ACTIVITIES OF DAILY LIVING; ADULT; ANTIPSYCHOTIC AGENTS; CLOZAPINE; COMBINED MODALITY THERAPY; FEMALE; HUMANS; INTERNAL-EXTERNAL CONTROL; MALE; MIDDLE AGED; PSYCHOTHERAPY; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SOCIAL ADJUSTMENT;

EID: 0031229049     PISSN: 02793695     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (4)

1. Asarnow, R., & MacCrimmon, D. (1982). Attention/information processing, neuropsychological functioning, and thought disorder in the acute and partial recovery phases of schizophrenia: A longitudinal study. Psychiatry Research, 7, 309-319.
2. Liberman, R., Corrigan, P., & Schade, M. (1989). The interaction of drug and psychosocial treatment. International Review of Psychiatry, 1, 283-284.
3. Schizophrenia update - Part II.(1995). The Harvard Mental Health Letter, 12, 1-3.
4. Yalom, I. (1970). The theory and practice of group psychotherapy. New York: Basic Books.